Novavax, Inc. Overview
Company Headquarters: Maryland, US
Founded: 1987
Workforce: ~2,500
Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa
Strategy
Novavax, Inc.'s main focus is to meet the unmet demand for emerging threats. It is focusing on building healthy relationships with academic and research institutes and pharmaceutical companies to develop cutting-edge biodefense solutions. Moreover, it is forming strategic alliances through funding and investment to support government agencies. Furthermore, it is committed to delivering novel products that leverage its innovative proprietary recombinant protein-based nanoparticle technology
